1,563
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Eight-year follow-up of airway hyperresponsiveness in patients with primary Sjögren’s syndrome

, , , &
Pages 51-55 | Received 12 Feb 2016, Accepted 16 Sep 2016, Published online: 16 Nov 2016

References

  • Moutsopoulos H, Chused T, Mann D, Klippel J, Fauci A, Frank M, et al. Sjögren’s syndrome (sicca syndrome): current issues. Ann Intern Med. 1980;92:212–26.
  • Vitali C, Tavoni A, Viegi G, Begliomini E, Agnes A, Bombardier S. Lung involvement in Sjögren’s syndrome: a comparison between patients with primary and with secondary syndrome. Ann Rheum Dis. 1985;44:455–61.
  • Lahdensuo A, Korpela M. Pulmonary findings in patients with primary Sjögren’s syndrome. Chest. 1995;108:316–19.
  • Kelly C, Gardiner P, Pal B, Griffiths I. Lung function in primary Sjögren’s syndrome: a cross sectional and longitudinal study. Thorax. 1991;46:180–3.
  • Gardiner P, Ward C, Allison A, Ashcroft T, Simpson W, Walters H, et al. Pleuropulmonary abnormalities in primary Sjögren’s syndrome. J. Rheumatol. 1993;20:831–7.
  • Contantopoulos S, Papadimitriou C, Moutsopoulos H. Respiratory manifestations in primary Sjögren’s syndrome. Chest. 1985;88:226–9.
  • Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S. Pulmonary manifestations of Sjögren’s syndrome. Eur Respir Rev. 2016;25:110–23.
  • Gudbjörnsson B, Hedenström H, Stålenheim G, Hällgren R. Bronchial hyperresponiveness to methacholine in patients with primary Sjögren’s syndrome. Ann Rheum Dis. 1991;50:36–40.
  • Potena A, La Corte R, Fabbri L, Papi A, Trotta F, Ciaccia A. Increased bronchial responsiveness in primary and secondary Sjogren’s syndrome. Eur Respir J. 1990;3:548–53.
  • Newball H, Brahim S. Chronic obstructive airway disease in patients with primary Sjögren’s syndrome. Am Rev Resp Dis. 1977;115:295–304.
  • Linstow M, Kriegbaum N, Backer V, Ulrik C, Oxholm P. A follow-up study of pulmonary function in patients with primary Sjögren’s syndrome. Rheumatol Int. 1990;10:47–9.
  • Davidson B, Kelly C, Griffiths I. Ten year follow up of pulmonary function in patients with primary Sjogren’s syndrome. Ann Rheum Dis. 2000;59:709–12.
  • Manthorpe R, Oxholm P, Prause J, Schiodt M. The Copenhagen criteria for Sjögren’s syndrome. Scand J Rheumatol. 1986;61(suppl):19–21.
  • Goules AV, Tzioufas AG, Moutsopoulos HM. Classification criteria of Sjögren’s syndrome. J Autoimmun. 2014;48–9:42–5.
  • American Thoracic Society. Standardization of spirometry 1994 update. Am J Respir Crit Care Med. 1995;152:1107–36.
  • Hedenström H, Malmberg P, Agarwai K. Reference values for lung function tests in females: regression equations with smoking variables. Bull Eur Physiopathol Respir. 1985;21:551–7.
  • Hedenström H, Malmberg P, Fridriksson H. Reference values for lung function tests in men: regression equations with smoking variables. Ups J Med Sci. 1986;91:299–310.
  • Hargreave F, Ryan G, Thomson N, O’Byrne P, Latimer K, Juniper E. Bronchial responsiveness to histamine or methacholine in asthma: measurements and clinical significance. Eur J Resp Dis. 1982;63(suppl 121):79–88.
  • Taouli B, Brauner MW, Mourey I, Lemouchi D, Grenier PA. Thin-section chest CT findings of primary Sjögren’s syndrome: correlation with pulmonary function. Eur Radiol. 2002;12:1504–11.
  • Oddera S, Silvestri M, Balbo A, Jovovich B, Penna R, Crimi E, et al. Airway eosinophilic inflammation, epithelial damage, and bronchial hyperresponsiveness in patients with mild-moderate, stable asthma. Allergy. 1996;51:100–7.
  • Lim S, Jatakanon A, John M, Gilbey T, O’Connor B, Chung K, et al. Effect of inhaled budesonide on lung function and airway inflammation. Am J Respir Crit Care Med. 1999;159:22–30.
  • Stålenheim G, Gudbjörnsson B. Anti-inflammatory drugs do not alleviate bronchial hyperreactivity in Sjögren’s syndrome. Allergy. 1997;52:423–7.
  • Lúdvíksdóttir D, Janson C, Björnsson E, Stålenheim G, Boman G, Hedenström D, et al. Different airway responsiveness profiles in atopic asthma, nonatopic asthma and Sjögren’s syndrome. BHR study group. Allergy. 2000;55:259–65.
  • Lúdvíksdóttir D, Jansson C, Högman M, Gudbjörnsson B, Björnsson E, Valtýsdóttir ST, et al. Increased nitric oxide in expired air in patients with Sjögren’s syndrome. Eur Respir J. 1999;13:739–43.
  • Moutsopoulos H. Sjögren’s syndrome: autoimmune epithelitis. Clin Immunol Immunopathol. 1994;72:162–5.
  • Papiris S, Maniati M, Contantopoulos S, Roussos C, Moutsopoulos H, Skopouli F. Lung involvement in primary Sjögren’s syndrome is mainly related to the small airway disease. Ann Rheum Dis. 1999;58:61–4.
  • Deheinzelin D, Capelozzi V, Kairalla R, Filho J, Saldiva P, de Carvalho C. Interstitial lung disease in primary Sjögren’s syndrome. Am J respir Crit Care Med. 1996;154:794–9.
  • Hatron P, Wallaert B, Gosset D, Tonnel A, Voisin C. Subclinical lung inflammation in primary Sjögren’s syndrome: relationship between bronchoalveolar lavage cellular analysis findings and characteristics of the disease. Arthritis Rheum. 1987;30:1226–31.
  • Dalavanga Y, Constantopoulos S, Galanopoulo V, Zerva L, Moutsopoulos H. Alveolitis correlates with clinical pulmonary involvement in primary Sjögren’s syndrome. Chest. 1991;99:1394–7.
  • Salaffi F, Manganelli P, Carotti M, Baldelli S, Blasetti P, Subiaco S, et al. A longitudinal study of pulmonary involvement in primary Sjögren’s syndrome: relationship between alveolitis and subsequent lung changes on high-resolution computed tomography. Br J Rheumatol. 1998;37:263–9.
  • Gudbjörnsson B, Hällgren R, Nettebladt O, Gustafsson R, Mattson A, af Geijerstam E, et al. Phenotypic and functional activation of alveolar macrophages, T-lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren’s syndrome. Ann Rheum Dis. 1994;53:574–9.